首页> 外文期刊>Clinical nuclear medicine >The Utility of Ga-68-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer
【24h】

The Utility of Ga-68-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer

机译:GA-68-PSMA PET / CT在分化不良转移前列腺癌中的效用

获取原文
获取原文并翻译 | 示例
           

摘要

We aimed to emphasize how useful PSMA PET/CT findings can be while trying to restage prostate cancer after radical prostatectomy in the presence of low prostate-specific antigen values. A 64-year-old man with pT3b N1 M0 Gleason 7 adenocarcinoma of the prostate presented 5 years postoperatively with a palpable axillary mass, whereas his prostate-specific antigen was 0.08 ng/mL. Conventional imaging studies and histopathologic findings of the axillary mass biopsy revealed inconclusive results. Ga-68-PSMA PET/CT demonstrated PSMA-positive metastatic lesions, the largest one being located in the right axilla. This finding confirmed metastatic poorly differentiated prostate cancer, and androgen deprivation therapy was initiated.
机译:我们的目标是强调PSMA宠物/ CT发现的发现,同时在试图在低前列腺特异性抗原值存在后恢复激进前列腺切除术后的前列腺癌。 一个64岁的男子患有PT3B N1 M0 GLEASON 7前列腺术术后5年腺癌,其前列腺特异性抗原为0.08 ng / mL。 腋窝肿块活检的常规成像研究和组织病理学发现揭示了不确定的结果。 GA-68-PSMA PET / CT显示了PSMA阳性转移性病变,最大的一个位于右腋下。 该发现已确认的转移性差异化的前列腺癌,并开始雄激素剥夺治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号